MétaCan
Menu
Back to cohort
Record W4376613717 · doi:10.1016/j.esmoop.2023.101290

66P Digital profiling of immune biomarkers: Relation to anthracycline benefit

2023· article· en· W4376613717 on OpenAlexaffabout
Elahe Shenasa, Yujun He, Zhonghua Wang, Dongsheng Tu, Dongxia Gao, Zuzana Kos, S. Thornton, Torsten O. Nielsen

Bibliographic record

VenueESMO Open · 2023
Typearticle
Languageen
FieldMedicine
TopicCancer Immunotherapy and Biomarkers
Canadian institutionsVancouver General HospitalQueen's UniversityUniversity of British Columbia
Fundersnot available
KeywordsCyclophosphamideBreast cancerOncologyImmune systemAnthracyclineMedicineEpirubicinInternal medicineChemotherapyImmunologyCancer

Abstract

fetched live from OpenAlex

Recent studies have shown that the tumor microenvironment can shape the response to immune-modulating therapies. Anthracyclines are a major chemotherapy regimen for breast cancer that induce immunogenic cell death. We hypothesized that patients with “immune hot” tumors may benefit from anthracyclines more than patients with “immune cold” tumors. As one of the largest breast cancer studies using the GeoMx digital spatial profiling, we tested this hypothesis by profiling 35 biomarkers on 536 cases obtained from the Canadian Cancer Trials Group MA.5 phase III clinical trial. In this trial, node-positive breast cancer patients were randomized to receive either a cyclophosphamide-based (cyclophosphamide-methotrexate-fluorouracil (CMF)) or anthracycline-containing adjuvant chemotherapy (cyclophosphamide-epirubicin-fluorouracil (CEF)). Tissue microarray sections were stained with barcoded antibodies to obtain digitally quantified biomarker counts. Unsupervised hierarchical clustering revealed two patient clusters: immune infiltrated and ignored. Following a pre-specified statistical plan crafted to meet ReMARK (REporting recommendations for tumor MARKer prognostic studies) guidelines, we did not observe significant results for the primary hypotheses: Immune cluster assignment did not predict an improved 10-year relapse-free survival or overall survival for patients receiving CEF compared to CMF in the full cohort. However, some of our secondary hypotheses revealed a significant predictive value for immune cluster assignment and stromal tumor infiltrating lymphocytes assessed on hematoxylin and eosin (H&E)-stained sides for CEF benefit over CMF in the human epidermal growth factor receptor 2 (HER2)-enriched subset. As an exploratory analysis, supervised clustering of immune biomarkers suggested that low levels of TIM-3 and high levels of HLA-DR and PD-L1 were associated with an extra benefit from CEF compared with CMF. While novel multiplexing techniques provide a detailed insight into the tumor microenvironment, conventional H&E staining acts as a powerful tool to assess the value of immune microenvironment in predicting benefits from immunogenic chemotherapies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.722
Threshold uncertainty score0.358

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.035
GPT teacher head0.338
Teacher spread0.303 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueESMO OpenSame topicCancer Immunotherapy and BiomarkersFrench-language works237,207